craig Cloutier

Screening Male Kidney Transplant Candidates For Prostate Cancer May Do More Harm Than Good

Article
Kidney & Bladder Health
Men's Health
+2
Contributed byKrish Tangella MD, MBAFeb 04, 2016

Screening male kidney transplant candidates for prostate cancer may be more harmful than protective because it does not appear to prolong their survival but may interfere with the transplant process. The findings come from a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

Screening for prostate cancer by assessing prostate specific antigen (PSA) levels is highly controversial because PSA levels may be elevated in a variety of disease processes. Also, even in the general population, the benefits of early treatment interventions for prostate cancer are unclear.

Currently, there are no guidelines for prostate cancer screening in patients with kidney disease who are undergoing evaluation for kidney transplantation; however, transplant centers generally rigorously screen candidates for potential malignancies to ensure that there are no contraindications to receiving a transplant.

For the first time, researchers now demonstrate that screening for prostate cancer in kidney transplant candidates is not beneficial, and may actually be harmful. When investigators led by Nicole Turgeon, MD, Blayne Amir Sayed, MD, PhD (Emory University), and Gerardo Vitiello, MD (NYU Langone Medical Center) retrospectively analyzed information on 3782 male patients undergoing kidney transplant evaluations at a single transplant center during a 10-year period, they discovered the following:

  • PSA screening was not associated with improved patient survival after transplantation.
  • PSA screening increased the time to listing and transplantation for candidates under 70 years old whose PSA tests indicated elevated levels.
  • Compared with candidates who were not screened, PSA-screened candidates had a reduced likelihood of receiving a transplant regardless of their PSA level.

"Screening for prostate cancer appears to delay receiving a kidney transplant without a clear survival benefit, and thus should likely be avoided as a general screening tool in the kidney transplant candidate population," said Dr. Turgeon.


The above post is reprinted from materials provided by American Society of NephrologyNote: Materials may be edited for content and length.

Disclaimer: DoveMed is not responsible for the adapted accuracy of news releases posted to DoveMed by contributing universities and institutions.

Primary Resource:

Vitiello, G. A., Sayed, B. A., Wardenburg, M., Perez, S. D., Keith, C. G., Canter, D. J., ... & Turgeon, N. (2015). Utility of Prostate Cancer Screening in Kidney Transplant Candidates. Journal of the American Society of Nephrology, ASN-2014121182.

Was this article helpful

On the Article

Krish Tangella MD, MBA picture
Approved by

Krish Tangella MD, MBA

Pathology, Medical Editorial Board, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!